Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
ADAMTSL2 mutations determine the phenotypic severity in geleophysic dysplasia
Vladimir Camarena, Monique M. Williams, Alejo A. Morales, Mohammad F. Zafeer, Okan V. Kilic, Ali Kamiar, Clemer Abad, Monica A. Rasmussen, Laurence M. Briski, LéShon Peart, Guney Bademci, Deborah S. Barbouth, Sarah Smithson, Gaofeng Wang, Lina A. Shehadeh, Katherina Walz, Mustafa Tekin
Vladimir Camarena, Monique M. Williams, Alejo A. Morales, Mohammad F. Zafeer, Okan V. Kilic, Ali Kamiar, Clemer Abad, Monica A. Rasmussen, Laurence M. Briski, LéShon Peart, Guney Bademci, Deborah S. Barbouth, Sarah Smithson, Gaofeng Wang, Lina A. Shehadeh, Katherina Walz, Mustafa Tekin
View: Text | PDF
Resource and Technical Advance Genetics

ADAMTSL2 mutations determine the phenotypic severity in geleophysic dysplasia

  • Text
  • PDF
Abstract

Geleophysic dysplasia-1 (GD1) is an autosomal recessive disorder caused by ADAMTS-like 2 (ADAMTSL2) variants. It is characterized by distinctive facial features, limited joint mobility, short stature, brachydactyly, and life-threatening cardiorespiratory complications. The clinical spectrum spans from perinatal lethality to milder adult phenotypes. We developed and characterized cellular and mouse models, to replicate the genetic profile of a patient who is compound heterozygous for 2 ADAMTSL2 variants, namely p.R61H and p.A165T. The impairment of ADAMTSL2 secretion was observed in both variants, but p.A165T exhibited a more severe impact. Mice carrying different allelic combinations revealed a spectrum of phenotypic severity, from lethality in knockout homozygotes to mild growth impairment observed in adult p.R61H homozygotes. Homozygous and hemizygous p.A165T mice survived but displayed severe respiratory and cardiac dysfunction. The respiratory dysfunction mainly affected the expiration phase, and some of these animals had microscopic post-obstructive pneumonia. Echocardiograms and MRI studies revealed a significant systolic dysfunction, accompanied by a reduction of the aortic root size. Histology verified the presence of hypertrophic cardiomyopathy with myocyte hypertrophy, chondroid metaplasia, and mild interstitial fibrosis. This study revealed a substantial correlation between the degree of impaired ADAMTSL2 secretion and the severity of the observed phenotype in GD1.

Authors

Vladimir Camarena, Monique M. Williams, Alejo A. Morales, Mohammad F. Zafeer, Okan V. Kilic, Ali Kamiar, Clemer Abad, Monica A. Rasmussen, Laurence M. Briski, LéShon Peart, Guney Bademci, Deborah S. Barbouth, Sarah Smithson, Gaofeng Wang, Lina A. Shehadeh, Katherina Walz, Mustafa Tekin

×

Figure 8

Mutant ADAMTSL2 secretion is impaired in vivo.

Options: View larger image (or click on image) Download as PowerPoint
Mutant ADAMTSL2 secretion is impaired in vivo.
(A) ADAMTSL2 is detected ...
(A) ADAMTSL2 is detected in the total lysate from 8-month-old female mouse lungs. A band above 130 kDa is reduced in mutant ADAMTSL2. (B) Lung tissue from newborn KO mice (FRTLoxPKo / FRTLoxPKo) does not have a top band above 130 kDa. There is a bottom band of around 130 kDa that is substantially reduced in these animals. Red arrows mark the bands that correspond to the bands absent in KO mouse immunoblots and appear to be ADAMTSL2. Posttranslational modification of ADAMTSL2 can result in higher molecular weight. (C) Densitometry analysis of the top and bottom bands of ADAMTSL2/GAPDH ratio shows a reduction of ADAMTSL2 in mutant animals. (*, P < 0.05; **, P < 0.01, 1-way ANOVA.) (D–F) Active TGF-β measurement by ELISA in mouse tissues. (D) There is no significant increase of active TGF-β in the lung tissue of newborn KO animals compared to littermate WT. A 2-tailed t test was used to test significance. There is no significant increase of active TGF-β in adult mutant animals when compared to WT in the lung (E) or heart tissues (F). Data shown as mean ± SEM. One-way ANOVA was used to test significance.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts